The T-cell-inflamed tumor microenvironment as a paradigm for immunotherapy drug development

Immunotherapy. 2019 Feb;11(3):155-159. doi: 10.2217/imt-2018-0171.
No abstract available

Keywords: cancer immunology; checkpoint inhibitors; clinical immunology; clinical trial design; immunotherapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Drug Development
  • Humans
  • Immunologic Factors / immunology
  • Immunotherapy*
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Radiotherapy
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / pathology
  • Tumor Escape
  • Tumor Microenvironment / immunology*

Substances

  • Immunologic Factors